NR2F2 alleviates pulmonary fibrosis by inhibition of epithelial cell senescence
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Nuclear receptor NR2F2 is reduced in idiopathic pulmonary fibrosis (IPF). Lower NR2F2 expression promotes lung cell senescence and fibrosis, suggesting NR2F2 as a potential therapeutic target for IPF.
Area Of Science
- Pulmonary Medicine
- Cellular Biology
- Molecular Biology
Background
- Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with unknown causes and few treatments.
- Aging and cellular senescence are linked to IPF pathogenesis.
- Limited therapeutic options exist for IPF patients.
Purpose Of The Study
- To investigate the role of nuclear receptor subfamily 2 group F member 2 (NR2F2) in IPF.
- To explore NR2F2's involvement in lung epithelial cell senescence and fibrosis.
- To assess NR2F2 as a potential therapeutic target for lung fibrosis.
Main Methods
- Examined NR2F2 expression in IPF and bleomycin-induced lung fibrosis models.
- Assessed the effects of NR2F2 inhibition and overexpression on lung epithelial cells and fibroblasts.
- Investigated NR2F2's impact on DNA damage and senescence markers (p21, p16).
- Utilized adenovirus-mediated gene delivery in mice to study NR2F2's effect on bleomycin-induced lung fibrosis.
Main Results
- NR2F2 expression was reduced in IPF and fibrotic lungs, particularly in senescent epithelial cells.
- NR2F2 inhibition increased senescence markers and activated fibroblasts.
- NR2F2 overexpression alleviated epithelial cell senescence, inhibited fibroblast activation, and reduced DNA damage.
- Adenovirus-mediated NR2F2 overexpression attenuated lung fibrosis and senescence in mice.
Conclusions
- NR2F2 plays a critical role in regulating lung epithelial cell senescence.
- Targeting NR2F2 may offer a novel therapeutic strategy for lung cell senescence and fibrosis.
- NR2F2 represents a promising target for combating IPF and related fibrotic lung diseases.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...